Sibling rivalry in the E2F family

Nature Reviews Molecular Cell Biology

Volumn 3, Issue 1, 2002, Pages 11-20

  Trimarchi, Jeffrey M ^a   Lees, Jacqueline A ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; DNA BINDING PROTEIN; E2F6 PROTEIN, HUMAN; E2F6 PROTEIN, MOUSE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F6;

ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CHROMATIN; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; NEOPLASM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CHROMATIN; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F6 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; MICE; MODELS, GENETIC; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS;

EID: 0036371956     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm714     Document Type: Review

References (133)

1. Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512 (1999).
2. Nevins, J. R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258, 424-429 (1992).
3. Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262 (1998).
4. La Thangue, N. B. & Rigby, P. W. An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells. Cell 49, 507-513 (1987).
5. Bandara, L. R. & La Thangue, N. B. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 351, 494-497 (1991).
6. Girling, R. et al. A new component of the transcription factor DRTF1/E2F. Nature 362, 83-87 (1993).
7. Weinberg, R. A. The retinoblastoma gene and gene product. Cancer Surv. 12, 43-57 (1992).
8. DeGregori, J., Leone, G., Ohtani, K., Miron, A. & Nevins, J. R. E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev. 9, 2873-2887 (1995).
9. Schwarz, J. K. et al. Expression of the E2F1 transcription factor overcomes type-β transforming growth factor-mediated growth suppression. Proc. Natl Acad. Sci. USA 92, 483-487 (1995).
10. Mann, D. J. & Jones, N. C. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest. Curr Biol. 6, 474-483 (1996).
11. Bartek, J., Bartkova, J. & Lukas, J. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8, 805-814 (1996).
12. Sherr, C. J. Cancer cell cycles. Science 274, 1672-1677 (1996).
13. Mulligan, G. & Jacks, T. The retinoblastoma gene family, cousins with overlapping interests. Trends Genet. 14, 223-229 (1998).
14. Hu, N. et al. Heterozygous Rb-1 delta 20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogens 9, 1021-1027 (1994).
15. Williams, B. O., Morgenbesser, S. D., DePinho, R. A. & Jacks, T. Tumorigenic and developmental effects of combined germ-line mutations in Rb and p53. Cold Spring Harb. Symp. Quant. Biol. 59, 449-457 (1994).
16. Clarke, A. R. et al. Requirement for a functional Rb-1 gene in murine development. Nature 359, 328-330 (1992).
17. Jacks, T. et al. Effects of an Rb mutation in the mouse. Nature 359, 295-300 (1992).
18. Lee, E. Y. et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288-294 (1992).
19. Helin, K. et al. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70, 337-350 (1992).
20. Flemington, E. K., Speck, S. H. & Kaelin, W. G. Jr. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl Acad. Sci. USA 90, 6914-6918 (1993).
21. Helin, K., Harlow, E. & Fattaey, A. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13, 6501-6508 (1993).
22. Zhang, H. S. & Dean, D. C. Rb-mediated chromatin structure regulation and transcriptional repression. Oncogens 20, 3134-3138 (2001).
23. Brehm, A. et al. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597-601 (1998).
24. Luo, R. X., Postigo, A. A. & Dean, D. C. Rb interacts with histone deacetylase to repress transcription. Cell 92, 463-473 (1998).
25. Chen, T. T. & Wang, J. Y. Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function. Mol. Cell. Biol. 20, 5571-5580 (2000).
26. Dahiya, A., Gavin, M. R., Luo, R. X. & Dean, D. C. Role of the LXCXE binding site in Rb function. Mol. Cell. Biol. 20, 6799-6805 (2000).
27. Strobeck, M. W. et al. BRG-1 is required for RB-mediated cell cycle arrest. Proc. Natl Acad. Sci. USA 97, 7748-7753 (2000).
28. Zhang, H. S. et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101, 79-89 (2000).
29. Nielsen, S. J. et al. Rb targets histone H3 methylation and HP1 to promoters. Nature 412, 561-565 (2001). This study shows that pRB associates with both SUV39H1 and HP1 through its pocket domain. SUV39H1 cooperates with pRB in the transcriptional repression of the E2F-responsive cyclin E promoter. Moreover, in vivo ChIP assays show that HP1 is recruited to the cyclin E promoter in a pRB-dependent manner.
30. Vandel, L. et al. Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol. Cell. Biol. 21, 6484-6494 (2001).
31. Harbour, J. W. & Dean, D. C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14, 2393-2409 (2000).
32. Bannister, A. J. et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromodomain. Nature 410, 120-124 (2001).
33. Lachrer, M., O'Carrol, D., Rea, S., Mechtler, K. & Jenuwein, T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410, 116-120 (2001).
34. Helin, K. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8, 28-35 (1998).
35. Bandara, L. R., Buck, V. M., Zamanian, M., Johnston, L. H. & La Thangue, N. B. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J. 12, 4317-4324 (1993).
36. Helin, K. et al. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev. 7, 1850-1861 (1993).
37. Krek, W., Livingston, D. M. & Shirodkar, S. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262, 1557-1560 (1993).
38. Wu, C. L., Zukerberg, L. R., Ngwu, C., Harlow, E. & Lees, J. A. In vivo association of E2F and DP family proteins. Mol. Cell. Biol. 15, 2536-2546 (1995).
39. Trimarchi, J. M. et al. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl Acad. Sci. USA 95, 2850-2855 (1998).
40. Takahashi, Y., Rayman, J. B. & Dynlacht, B. D. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev. 14, 804-816 (2000). This study uses in vivo ChIP assays to examine the cell-cycle-dependent association of individual E2F and pocket proteins with several E2F-responsive promoters. In G0/G1, these promoters are primarily occupied by E2F4, p107 and p130. As cells enter late G1, there is a significant reduction in the binding of these proteins and E2F1, E2F2 and E2F3 now associate. There was no detectable difference in the spectrum of E2Fs at individual responsive genes, which indicates that they could all be regulated similarly.
41. Wells, J., Boyd, K. E., Fry, C. J., Bartley, S. M. & Famham, P. J. Target gene specificity of E2F and pocket protein family members in living cells. Mol. Cell. Biol. 20, 5797-5807 (2000).
42. Kaelin, W. G. Jr et al. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70, 351-364 (1992).
43. Shan, B. et al. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol. 12, 5620-5631 (1992).
44. Ivey-Hoyle, M. et al. Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol. Cel. Biol. 13, 7802-7812 (1993).
45. Lees, J. A. et al. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13, 7813-7825 (1993).
46. Leone, G. et al. Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins. Mol. Cell. Biol. 20, 3626-3532 (2000).
47. Johnson, D. G., Schwarz, J. K., Cress, W. D. & Nevins, J. R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365, 349-352 (1993).
48. Qin, X. Q., Livingston, D. M., Kaelin, W. G. Jr & Adams, P. D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl Acad. Sci. USA 91, 10918-10922 (1994).
49. Lukas, J., Petersen, B. O., Holm, K., Bartek, J. & Helin, K. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol. Cell. Biol. 16, 1047-1057 (1996).
50. Johnson, D. G., Cress, W. D., Jakoi, L. & Nevins, J. R. Oncogenic capacity of the E2F1 gene. Proc. Natl Acad. Sci. USA 91, 12823-12827 (1994).
51. Shan, B. & Lee, W. H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14, 8166-8173 (1994).
52. Singh, P., Wong, S. H. & Hong, W. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13, 3329-3338 (1994).
53. Xu, G., Livingston, D. M. & Krek, W. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl Acad. Sci. USA 92, 1357-1361 (1995).
54. Leone, G. et al. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 12, 2120-2130 (1998).
55. Humbert, P. O. et al. E2f3 is critical for normal cellular proliferation. Genes Dev. 14, 690-703 (2000). This study shows that E2F3 acts in a dose-dependent manner to mediate the mitogen-induced activation of almost all known E2F-responsive genes. As a result, E2F3 controls the rate of proliferation of both primary and transformed MEFs.
56. Wu, L. et al. The E2F1-3 transcription factors are essental for cellular proliferation. Nature 414, 457-462 (2001). Using the conditional mutant E2f alleles, the authors show that the combined loss of E2F1, E2F2 and E2F3 completely blocks the proliferation of MEFs. This is accompanied by an increase in the levels of the Cdk inhibitor p21.
57. Wu, X. & Levine, A. J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl Acad. Sci. USA 91, 3602-3606 (1994).
58. Hiebert, S. W. et al. E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol. Cell. Biol. 15, 6864-6874 (1995).
59. Hsieh, J. K., Fredersdorf, S., Kouzarides, T., Martin, K. & Lu, X. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11, 1840-1852 (1997).
60. Phillips, A. C., Bates, S., Ryan, K. M., Helin, K. & Vousden, K. H. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11, 1853-1863 (1997).
61. Phillips, A. C., Ernst, M. K., Bates, S., Rice, N. R. & Vousden, K. H. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol. Cell 4, 771-781 (1999).
62. DeGregori, J., Leone, G., Miron, A., Jakoi, L. & Nevins, J. R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl Acad. Sci. USA 94, 7245-7250 (1997).
63. Bates, S. et al. p14ARF links the tumour suppressors RB and p53. Nature 395, 124-125 (1998).
64. ARF is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo. Mol. Cell. Biol. 22, 370-377 (2002).
65. Tsai, K. Y. MacPherson, D., Rubionson. D. A., Crowley, D., and Jacks, T. ARF is not required for apoptosis in Rb mutant mouse embryos. Curr. Biol. (in the press).
66. Irwin, M. et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407, 645-648 (2000).
67. Lissy, N. A. Davis, P. K., Irwin, M., Kaelin, W. G. & Dowdy, S. F. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 407, 642-645 (2000).
68. Stiewe, T. & Putzer, B. M. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nature Genet. 26, 464-469 (2000).
69. Ishida, S. et al. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol. Cell. Biol. 21, 4684-4699 (2001).
70. Muller, H. et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15, 267-285 (2001).
71. Kowalik, T. F., DeGregori, J., Leone, G., Jakoi, L. & Nevins, J. R. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell Growth Differ. 9, 113-118, (1998).
72. Leone, G. et al. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol. Cell 8, 105-113 (2001).
73. Vigo, E. et al. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol. Cell. Biol. 19, 6379-6395 (1999).
74. Tsai, K. Y. et al. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell 2, 293-304 (1998). By intercrossing the Rb and E2f1 mutant mouse strains, the authors show that E2F1 loss causes a significant reduction in the levels of ectopic S-phase entry, p53-dependent-and p53-independent-apoptosis that arises in pRB-deficient embryos. This ameliorates the defective erythropofesis and thereby extends the lifespan of the embryo by several days.
75. Ziebold, U., Reza, T., Caron, A. & Lees, J. A. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev. 15, 386-391 (2001). This study shows that E2F3 loss almost completely suppresses the inappropriate proliferation, p53-dependent-and p53-independent-apoptosis in pRB-deficient embryos. As the degree of suppression exceeds that which results from the loss of E2F1, this indicates E2F3 can induce apoptosis in vivo independently of E2F1.
76. Pan, H. et al. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol. Cell 2, 283-292 (1998).
77. Yamasaki, L. et al. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-) mice. Nature Genet. 18, 360-364 (1998).
78. Field, S. J. et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549-561 (1996).
79. Yamasaki, L. et al. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537-548 (1996). This study examines the phenotypic consequences of E2F1 deficiency. In addition to various developmental defects, the E2f1 mutant mice were unexpectedly found to have an increased susceptibility to tumours.
80. Zhu, J. W., DeRyckere, D., Li, F. X. Wan, Y. Y. & DeGregori, J. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection. Cell Growth Differ. 10, 829-838 (1999).
81. Garcia, I., Murga, M., Vicario, A., Field, S. J. & Zubiaga, A. M. A role for E2F1 in the induction of apoptosis during thymic negative selection. Cell Growth Differ. 11, 91-98 (2000).
82. Humbert, P. O. et al. E2F4 is essential for normal erythrocyte maturation and neonatal viability. Mol. Cell 6, 281-291 (2000).
83. Meng, R. D., Phillips, P. & El-Deiry, W. S. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. Int. J. Oncol. 14, 5-14 (1999).
84. Lin, W. C., Lin, F. T. & Nevins, J. R. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15, 1833-1844 (2001).
85. Maser, R. S. et al. Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis. Mol. Cell. Biol. 21, 6006-6016 (2001).
86. Zhu, J. W. et al. E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis. Mol. Cell. Biol. 21, 8547-6564 (2001).
87. Dyson, N. et al. Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-asscciated E2F-1. J. Virol. 67, 7641-7647 (1993).
88. Beijersbergen, R. L. et al. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8, 2680-2690 (1994).
89. Hijmans, E. M., Voorhoeve, P. M., Beijersbergen, R. L., van't Veer, L. J. & Bernards, R. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15, 3082-3089 (1995).
90. Vairo, G., Livingston, D. M. & Ginsberg, D. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9, 869-881 (1995).
91. Ikeda, M. A., Jakoi, L. & Nevins, J. R. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl Acad. Sci. USA 93, 3215-3220 (1996).
92. Moberg, K., Starz, M. A. & Lees, J. A. E2F-4 switches from p130 to p107 and pRB in response to cell-cycle re-entry. Mol. Cell. Biol. 16, 1436-1449 (1996).
93. Muller, H. et al. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol. Cell. Biol. 17, 5508-5520 (1997). The authors show that the ability of the activating E2Fs to Induce quiescent cells to re-enter the cell cycle is dependent on their nuclear localization. This is determined by a canonical basic NLS within the amino-terminal domain. By contrast, E2F4 is unable to induce cell cycle re-entry as a result of its cytoplasmic localization.
94. Varona, R. et al. E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol. Cell. Biol. 17, 7268-7282 (1997). This study shows that ectopically expressed activating E2Fs are nuclear, whereas E2F4 is predominantly cytoplasmic, and the differential localization of these proteins accounts for the pronounced differences in their ability to activate transcription. It confirms that the endogenous E2F4-DP complexes are also sequestered In the cytoplasm and shows that these species become predominantly nuclear when they are bound to pRB or p130 in G0/G1. This indicates that E2F4 is primarily involved in the repression rather than the activation of E2F-responsive genes.
95. Magae, J., Wu, C. L. Illenye, S., Harlow, E. & Heintz, N. H. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J. Cell Sci., 109, 1717-1726 (1996).
96. Gaubatz, S., Lees, J. A., Lindeman, G. J. & Livingston, D. M. E2F4 is exported from the nucleus in a CRM1-dependent manner. Mol. Cell. Biol. 21, 1384-1392 (2001).
97. Iavarone, A. & Massague, J. E2F and histone deacetylase mediate transforming growth factor-β repression of cdc25A during keratinocyte cell cycle arrest. Mol. Cell. Biol. 19, 916-922 (1999).
98. Dalton, S. Cell cycle regulation of the human CDC2 gene. EMBO J. 11, 1797-1804 (1992).
99. Lam, E. W. & Watson, R. J. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12, 2705-2713 (1993).
100. Hsiao, K. M., McMahon, S. L. & Famham, P. J. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev. 8, 1526-1537 (1994).
101. Tommasi, S. & Pfeifer, G. P. In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol. Cell. Biol. 15, 6901-6913 (1995).
102. Huet, X., Rech, J., Plet, A., Vie, A. & Blanchard, J. M. Cyclin A expression is under negative transcriptional control during the cell cycle. Mol. Cell. Biol. 16, 3789-3798 (1996).
103. Zwicker, J., Liu, N., Engeland, K., Lucibello, F. C. & Muller, R. Cell cycle regulation of E2F site occupation in vivo. Science 271, 1595-1597 (1996).
104. Bruce, J. L., Hurford, R. K. Jr, Classon, M., Koh, J. & Dyson, N. Requirements for cell cycle arrest by p16INK4a. Mol. Cell 6, 737-742 (2000).
105. Gaubatz, S. et al. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol. Cell 6, 729-735 (2000). This study shows that E2f4-E2f5 double mutant MEFs are unable to arrest in response to the over-expression of the Cdk inhibitor p16, providing direct genetic evidence for the role of the repressive E2Fs in mediating cell-cycle exit
106. Hurford, R. K. Jr, Cobrinik, D., Lee, M. H. & Dyson, N. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11, 1447-1463 (1997). The combined loss of p107 and p130 is shown to cause a significant upregulation in the expression of known E2F-responsive genes in GO/G1 cells, and supports the role of these pocket proteins in the repression of these target genes.
107. Lindeman, G. J. et al. A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting. Genes Dev. 12, 1092-1093 (1998).
108. Rempel, R. E. et al. Loss of E2F4 activity leads to abnormal development of multiple cellular lineages. Mol. Cell 6, 293-306 (2000).
109. Persengiev, S. P., Kondova, I. I. & kilpatrick, D. L. E2F4 actively promotes the initiation and maintenance of nerve growth factor-induced cell differentiation. Mol. Cell. Biol. 19, 6048-6056 (1999).
110. Cobrinik, D. et al. Shared role of the pRB-related p130 and p107 proteins 'm limb development. Genes Dev. 10, 1633-1644 (1996).
111. Dahiya, A., Wong, S., Gonzalo, S., Gavin, M. & Dean, D. C. Linking the Rb and polycomb pathways. Mol. Cell 8, 557-569 (2001). This paper is one of an important series from the Dean lab that examines the ability of pRB to associate with historic-modifying enzymes and repress E2F-responsive genes. Its primary focus is to show that an E2F-pRB-CtBP-HPC2 complex can repress the cyclin A gene. However, it also provides key information about in vivo timing of the pRB-mediated transcriptional repression. Using ChIP assays, the authors confirm the finding that pRB does not associate with E2F-responsive promoters in cells that retain the ability to divide. They further show that pRB becomes promoter bound In cells that have to be Induced to exit the cell cycle permanently through the sustained expression of p16.
112. Altiok, S., Xu, M. & Spiegelman, B. M. PPAR-γ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev. 11, 1987-1998 (1997).
113. Stomiany, B. A., D'Ańgo, K. L, Kelly, M. M. & Kurtz, D. T. C/EBPα inhibits cell growth via direct repression of E2F-DP-mediated transcription. Mol. Cell. Biol. 20, 5986-5997 (2000).
114. Porse, B. T. et al. E2F repression by C/EBPα is required for adipogenesis and granulopoiesis in vivo. Cell 107, 247-258 (2001).
115. Chen, P. L., Riley, D. J., Chen, Y. & Lee, W. H. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10, 2794-2804 (1996).
116. Chen, P. L., Riley, D. J., Chen-Kiang, S. & Lee, W. H. Retinoblastoma protein directly interacts with and activates the transcription factor NF-1L6. Proc. NatlAcad. Sci. USA 93, 455-469 (1996).
117. Thomas, D. M. et al. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol. Cell 8, 303-316 (2001).
118. Morkel, M., Wenkel, J., Bannister, A. J., Kouzarides, T. & Hagemeier, C. An E2F-like repressor of transcription. Nature 390, 567-568 (1997).
119. Cartwright, P., Muller, H., Wagener, C., Holm, K. & Helin, K. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene 17, 611-623 (1998).
120. Gaubatz, S., Wood, J. G. & Livingston, D. M. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc. Natl Acad. Sci. USA 95, 9190-9195 (1998).
121. Trimarchi, J. M., Fairchild, B., Wen, J. & Lees, J. A. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc. Natl Acad. Sci. USA 98, 1519-1524 (2001).
122. van Lohuizen, M. Functional analysis of mouse Polycomb group genes. Cell Mol. Life Sci. 54, 71-79 (1998).
123. Jacobs, J. J. & van Lohuizen, M. Cellular memory of transcriptional states by Polycomb-group proteins. Semin. Cell Dev. Biol. 10, 227-235 (1999).
124. Francis, N. J. & Kingston, R. E. Mechanisms of transcriptional memory. Nature Rev. Mol. Cell Biol. 2, 409-421 (2001).
125. Haupt, Y., Alexander, W. S., Barri, G., Klinken, S. P. & Adams, J. M. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in μ-myc transgenic mice. Cell 65, 753-763 (1991).
126. van Lohuizen, M. et al. Identification of cooperating oncogenes in μ-myc transgenic mice by provirus tagging. Cell 65, 737-752 (1991).
127. Jacobs, J. J. et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13, 2673-2690 (1999).
128. Dynlacht, B. D., Brook, A., Dembski, M., Yenush, L. & Dyson, N. DNA-binding and trans-activation properties of Drosophila E2F and DP proteins. Proc. Natl Acad. Sci. USA 91, 6359-6363 (1994).
129. Frolov, M. V. et al. Functional antagonism between E2F family members. Genes Dev. 15, 2146-2160 (2001). Drosophila has two E2Fs, dE2F1 and dE2F2. This paper shows that dE2F2 is a repressor of E2F-responsive genes and its mutation almost completely suppresses the phenotypic defects that result from dE2F1-loss. So, dE2F1 and dE2F2 antagonize each others function in vivo.
130. Dyson, N. & Harlow, E. Adenovirus E1A targets key regulators of cell proliferation. Cancer Surv. 12, 161-195 (1992).
131. Lee, M. H. et al. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10, 1621-1632 (1996).
132. Aalfs, J. D. & Kingston, R. E. What does 'chromatin remodeling' mean? Trends Biochem Sci. 25, 548-555 (2000).
133. Jenuwein, T. & Allis, C. D. Translating the histone code. Science 293, 1074-1080 (2001).